Abstract
ObjectivesDevelopment of non-Hodgkin’s lymphoma (NHL) is the major adverse outcome of Sjögren’s syndrome (SS) affecting both morbidity and mortality. Preliminary evidence suggested that, although not deregulated compared with sicca controls,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have